- $1.99bn
- $2.41bn
- $2.43bn
- 87
- 64
- 97
- 96
2019 December 28th | 2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | |
---|---|---|---|---|---|
Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,247 | 1,955 | 2,362 | 2,184 | 2,434 |
Cost of Revenue | |||||
Gross Profit | 834 | 721 | 844 | 765 | 948 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,096 | 1,894 | 2,207 | 2,099 | 2,344 |
Operating Profit | 151 | 61.4 | 155 | 85.4 | 90.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 143 | 54.4 | 146 | 78.3 | 64.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 111 | 41.9 | 124 | 59.8 | 49.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 111 | 41.9 | 124 | 59.8 | 49.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 111 | 41.9 | 124 | 59.8 | 49.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.58 | 1.79 | 2.24 | 1.63 | 1.83 |
Dividends per Share |